Immuron IMRN
NASDAQ IMRN
$0.98 -0.04 (-3.85%)
As of: Oct 21, 2026 · 1:49 PM EDT

Immuron (IMRN) Share-based Compensation (2018 - 2021)

Updated

Immuron (IMRN) reported Share-based Compensation of $60,070 for FY2026 (year ended Jun 30, 2026), down 69.5% from $197,189 in FY2025.

Analysis

Immuron (IMRN) Share-based Compensation (2018 - 2021) Analysis & Trends

Dating back to FY2018, Immuron's Share-based Compensation record includes 9 fiscal years.

  • Share-based Compensation has a five-year compound annual growth rate of -48.0% (FY2021 to FY2026).
  • Five-year annual Share-based Compensation spans a low of $2,164 in FY2024 and a high of $197,189 in FY2025.
  • According to Business Quant data, Share-based Compensation came in at $197,189 in FY2025, $2,164 in FY2024 (-98.6%), $152,835 in FY2023 (+121.9%) and $68,887 in FY2022 (-95.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,137.26 Bn 1,105.84 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 618.12 Bn 536.65 Bn 17.26 Bn 458.00 Mn
3 AbbVie 503.25 Bn 476.36 Bn 12.70 Bn 166.00 Mn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 298.45 Bn 262.44 Bn 11.24 Bn -
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn -
7 Amgen 237.30 Bn 192.70 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 191.35 Bn 165.55 Bn 6.22 Bn 231.00 Mn
9 Pfizer 169.92 Bn 116.56 Bn 10.94 Bn 249.00 Mn
10 Immuron 7.28 Mn -9.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 1.63 Mn
Sep 1, 2020 -533,912.00
Jun 30, 2020 -349,936.94
Dec 31, 2019 1.34 Mn
Aug 30, 2019 1.34 Mn
Dec 31, 2018 242,950.00
API Access

Immuron Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMRN&period=max&api_key=YOUR_API_KEY